TY - JOUR
T1 - Time dependent amelioration against ischemic brain damage by glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat
AU - Zhang, W. R.
AU - Hayashi, T.
AU - Iwai, M.
AU - Nagano, I.
AU - Sato, K.
AU - Manabe, Y.
AU - Abe, K.
N1 - Funding Information:
This work was partly supported by Grants-in-Aid for Scientific Research (B) 12470141 and (Hoga) 12877211 from the Ministry of Education, Science, Culture and Sports of Japan, and by Grants (Tashiro K, Itoyama Y) and Comprehensive Research on Aging and Health (H11-Choju-010, No. 207, Koizumi A) from the Ministry of Health and Welfare of Japan, and by Grants-in-Aid from Japanese–Chinese Medical Association.
PY - 2001/6/8
Y1 - 2001/6/8
N2 - Time dependent influence of glial cell line-derived neurotrophic factor (GDNF) was examined after 90 min of transient middle cerebral artery occlusion (MCAO) in rats. Treatment with GDNF significantly reduced the infarct volume stained with 2,3,5-triphenyltetrazolium chloride (TTC) when GDNF was topically applied at 0 and 1 h of reperfusion, but became insignificant at 3 h as compared to vehicle group. The protective effect of GDNF was closely related to the significant reduction of the number of terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick end labeling (TUNEL) positive cells as well as immunofluorescently positive cells for active forms of caspases, especially active caspase-3 but not -9. Thus, the present study showed that topical application of GDNF significantly reduced infarct size in a time-dependent manner, while the therapeutic time window was shorter than other chemical compounds such as an NMDA receptor antagonist (MK-801) and a free radical scavenger (alpha-phenyl-tert-butyl-nitrone, PBN). The effect of GDNF was stronger in suppressing active caspase-3 than active caspase-9.
AB - Time dependent influence of glial cell line-derived neurotrophic factor (GDNF) was examined after 90 min of transient middle cerebral artery occlusion (MCAO) in rats. Treatment with GDNF significantly reduced the infarct volume stained with 2,3,5-triphenyltetrazolium chloride (TTC) when GDNF was topically applied at 0 and 1 h of reperfusion, but became insignificant at 3 h as compared to vehicle group. The protective effect of GDNF was closely related to the significant reduction of the number of terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick end labeling (TUNEL) positive cells as well as immunofluorescently positive cells for active forms of caspases, especially active caspase-3 but not -9. Thus, the present study showed that topical application of GDNF significantly reduced infarct size in a time-dependent manner, while the therapeutic time window was shorter than other chemical compounds such as an NMDA receptor antagonist (MK-801) and a free radical scavenger (alpha-phenyl-tert-butyl-nitrone, PBN). The effect of GDNF was stronger in suppressing active caspase-3 than active caspase-9.
KW - Caspase-3
KW - Caspase-9
KW - Glial cell line-derived neurotrophic factor (GDNF)
KW - Ischemia
KW - Terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick end labeling (TUNEL)
UR - http://www.scopus.com/inward/record.url?scp=0035827079&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035827079&partnerID=8YFLogxK
U2 - 10.1016/S0006-8993(01)02364-2
DO - 10.1016/S0006-8993(01)02364-2
M3 - Article
C2 - 11382412
AN - SCOPUS:0035827079
SN - 0006-8993
VL - 903
SP - 253
EP - 256
JO - Molecular Brain Research
JF - Molecular Brain Research
IS - 1-2
ER -